Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction
- PMID: 12020175
- DOI: 10.1001/archinte.162.10.1091
Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction
Comment in
-
Lack of cardioprotective effect of naproxen.Arch Intern Med. 2002 Dec 9-23;162(22):2637; author reply 2638-9. doi: 10.1001/archinte.162.22.2637. Arch Intern Med. 2002. PMID: 12456255 No abstract available.
-
Aspirin use may change cost-effectiveness of COX-2 inhibitors.Arch Intern Med. 2002 Dec 9-23;162(22):2637-8; author reply 2638-9. doi: 10.1001/archinte.162.22.2637-a. Arch Intern Med. 2002. PMID: 12456256 No abstract available.
-
Naproxen's interaction with aspirin may affect its cardioprotective effect.Arch Intern Med. 2003 Jun 9;163(11):1374. doi: 10.1001/archinte.163.11.1374-a. Arch Intern Med. 2003. PMID: 12796081 No abstract available.
Comment on
-
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction.Arch Intern Med. 2002 May 27;162(10):1099-104. doi: 10.1001/archinte.162.10.1099. Arch Intern Med. 2002. PMID: 12020178
-
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis.Arch Intern Med. 2002 May 27;162(10):1105-10. doi: 10.1001/archinte.162.10.1105. Arch Intern Med. 2002. PMID: 12020179
-
Association between naproxen use and protection against acute myocardial infarction.Arch Intern Med. 2002 May 27;162(10):1111-5. doi: 10.1001/archinte.162.10.1111. Arch Intern Med. 2002. PMID: 12020180
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials